Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,722 INR | -1.84% | +0.60% | +2.39% |
May. 14 | Transcript : Zydus Wellness Limited, Q4 2024 Earnings Call, May 14, 2024 | |
May. 14 | Zydus Wellness Sees Rise in Fiscal Q4 Consolidated Net Profit | MT |
Strengths
- The company returns high margins, thereby supporting business profitability.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With an expected P/E ratio at 36.84 and 27.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.39% | 1.34B | C+ | ||
-1.08% | 277B | A- | ||
-7.02% | 91.92B | C+ | ||
-5.15% | 42.95B | C+ | ||
+0.95% | 41.25B | B- | ||
+5.05% | 40.01B | B- | ||
+4.14% | 38.81B | B- | ||
-14.89% | 30.87B | B- | ||
-11.47% | 27.21B | A | ||
+8.20% | 24.19B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ZYDUSWELL Stock
- Ratings Zydus Wellness Limited